Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice
Prakash, N.J.; Schechter, P.J.; Grove, J.; Koch-Weser, J.
Cancer Research 38(9): 3059-3062
1978
ISSN/ISBN: 0008-5472 PMID: 679213 Document Number: 127262
Document emailed within 1 workday
Related Documents
Slotkin, T.A.; Seidler, F.J.; Trepanier, P.A.; Whitmore, W.L.; Lerea, L.; Barnes, G.A.; Weigel, S.J.; Bartolome, J. 1982: Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase Journal of Pharmacology and Experimental Therapeutics 222(3): 741-745Emanuelsson, H.; Heby, O. 1983: Nuclear ornithine decarboxylase. Electron microscope autoradiographic identification of the active enzyme using alpha-[5-3H]difluoromethylornithine European Journal of Cell Biology 30(2): 288-294
Claverie, N.; Mamont, P.S. 1989: Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs Cancer Research 49(16): 4466-4471
Bartholeyns, J.; Koch-Weser, J. 1981: Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats Cancer Research 41(12 Pt 1): 5158-5161
Kramer, D.L.; Paul, B.; Porter, C.W. 1985: Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice Cancer Research 45(6): 2512-2515
Ajani, J.A.; Ota, D.M.; Grossie, V.B.; Levin, B.; Nishioka, K. 1989: Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels Cancer Research 49(20): 5761-5765
Bowlin, T.L.; McKown, B.J.; Davis, G.F.; Sunkara, P.S. 1986: Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice Cancer Research 46(11): 5494-5498
Hui, K.S. 1976: The effect of thiazol-4-yimethoxyamine, a histidine decarboxylase inhibitor, on the development of morphine tolerance and physical dependance in mice Experientia 32(10): 1313-1315
Knopp, J.; Brtko, J. 1990: Nuclear binding of thyroid hormones and activity of malic enzyme and ornithine decarboxylase in rat liver during postnatal development Endocrinologia Experimentalis 24(4): 429-435
Marx, M.; Townsend, C.M.; Barranco, S.C.; Glass, E.J.; Thompson, J.C. 1987: Treatment of hamster pancreatic cancer with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis Journal of the National Cancer Institute 79(3): 543-548
Pontiroli, A.E.; Castegnaro, E.; Vettaro, M.P.; Viberti, G.C.; Pozza, G. 1977: Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine Acta Endocrinologica 84(1): 36-44
Verma, A.K.; Boutwell, R.K. 1977: Vitamin a acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis Cancer Research 37(7 Part 1): 2196-2201
Guarnieri, C.; Muscari, C.; Flamigni, F.; Caldarera, C.R. 1983: Effect of catecholamines on ornithine decarboxylase activity monitored in the perfused rat heart Italian Journal of Biochemistry 32(2): 77-83
Sundberg, J.P.; Erickson, A.A.; Roop, D.R.; Binder, R.L. 1994: Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10 Cancer Research 54(5): 1344-1351
Fukuda, C.; Iijima, K.; Inoue, N.; Takashima, Y.; Urabe, C.; Nakamura, K. 1988: Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery Rinsho Byori. Japanese Journal of Clinical Pathology 36(3): 346-350
Błaszkowska, J.; Kadłubowski, R. 2001: Preliminary evaluation of maternotoxic effect of Ascaris alpha-chymotrypsin inhibitor in mice Wiadomosci Parazytologiczne 47(4): 705-710
Nakano, M.; Kanda, T.; Matsuzaki, S.; Hasegawa, S.; Ma, H.; Imai, S.; Suzuki, T.; Kobayashi, I. 1995: Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity Research Communications in Molecular Pathology and Pharmacology 88(1): 21-30
Veselá, J.; Drsata, J. 1988: The effect of 5-[2-(N,N-dimethylamino)ethoxy]-7-oxo-7H-benzo(c) fluorene hydrochloride (Benfluron, a cytostatic) on ornithine decarboxylase activity in the regenerating rat liver in vivo Ceskoslovenska Farmacie 37(6): 251-254
Raunio, H.; Pelkonen, O. 1983: Effect of polycyclic aromatic compounds and phorbol esters on ornithine decarboxylase and aryl hydrocarbon hydroxylase activities in mouse liver Cancer Research 43(2): 782-786
Bulger, W.H.; Kupfer, D. 1976: The effect of CC14 on uterine ornithine decarboxylase (ODC) in the rat. Inhibition by CC14 of the induction of ODC by E2 and o,p'DDT Research Communications in Chemical Pathology and Pharmacology 14(3): 497